Abstract:Osteocytes remodel the perilacunar matrix and canaliculi. X-linked hypophosphatemia (XLH) is characterized by elevated serum levels of fibroblast growth factor 23 (FGF23), leading to decreased 1,25 dihydroxyvitamin D 3 (1,25D) production and hypophosphatemia. Bones from mice with XLH (Hyp) have enlarged osteocyte lacunae, enhanced osteocyte expression of genes of bone remodeling, and impaired canalicular structure. The altered lacuno-canalicular (LCN) phenotype is improved with 1,25D or anti-FGF23 antibody treatment, pointing to roles for 1,25D and/or phosphate in regulating this process. To address whether impaired 1,25D action results in LCN alterations, the LCN phenotype was characterized in mice lacking the vitamin D receptor (VDR) in osteocytes (VDR f/f;DMP1Cre+ ). Mice lacking the sodium phosphate transporter NPT2a (NPT2aKO) have hypophosphatemia and high serum 1,25D levels, therefore the LCN phenotype was characterized in these mice to determine if increased 1,25D compensates for hypophosphatemia in regulating LCN remodeling. Unlike Hyp mice, neither VDR f/f;DMP1Cre+ nor NPT2aKO mice have dramatic alterations in cortical microarchitecture, allowing for dissecting 1,25D and phosphate specific effects on LCN remodeling in tibial cortices. Histomorphometric analyses demonstrate that, like Hyp mice, tibiae and calvariae in VDR f/f;DMP1Cre+ and NPT2aKO mice have enlarged osteocyte lacunae (tibiae: 0.15±0.02μm 2 (VDR f/f;DMP1Cre- ) vs 0.19±0.02μm 2 (VDR f/f;DMP1Cre+ ), 0.12±0.02μm 2 (WT) vs 0.18±0.0μm 2 (NPT2aKO), calvariae: 0.09±0.02μm 2 (VDR f/f;DMP1Cre- ) vs 0.11±0.02μm 2 (VDR f/f;DMP1Cre+ ), 0.08±0.02μm 2 (WT) vs 0.13±0.02μm 2 (NPT2aKO), p<0.05 all comparisons) and increased immunoreactivity of bone resorption marker Cathepsin K (Ctsk). The osteocyte enriched RNA isolated from tibiae in VDR f/f;DMP1Cre+ and NPT2aKO mice have enhanced expression of matrix resorption genes that are classically expressed by osteoclasts ( Ctsk , Acp5 , Atp6v0d2 , Nhedc2 ). Treatment of Ocy454 osteocytes with 1,25D or phosphate inhibits the expression of these genes. Like Hyp mice, VDR f/f;DMP1Cre+ and NPT2aKO mice have impaired canalicular organization in tibia and calvaria. These studies demonstrate that hypophosphatemia and osteocyte-specific 1,25D actions regulate LCN remodeling. Impaired 1,25D action and low phosphate levels contribute to the abnormal LCN phenotype observed in XLH.

The role of GDF5 in regulating enthesopathy development in the Hyp mouse model of XLH

Impaired 1,25-dihydroxyvitamin D3 action underlies enthesopathy development in the Hyp mouse model of X-linked hypophosphatemia

Mineralizing Enthesopathy Is a Common Feature of Renal Phosphate-Wasting Disorders Attributed to FGF23 and Is Exacerbated by Standard Therapy in Hyp Mice

Impact of Broad Regulatory Regions on Gdf5 Expression and Function in Knee Development and Susceptibility to Osteoarthritis.

Complex intrinsic abnormalities in osteoblast lineage cells of X-linked hypophosphatemia: Analysis of human iPS cell models generated by CRISPR/Cas9-mediated gene ablation

FGF23 and its role in X-linked hypophosphatemia-related morbidity

The Role of Gdf5 Regulatory Regions on Development of Hip Morphology and Susceptibility to Osteoarthritis and Dislocation

Targeted deletion of Fgf9 in tendon disrupts mineralization of the developing enthesis

Impaired 1,25 dihydroxyvitamin D3 action and hypophosphatemia underlie the altered lacuno-canalicular remodeling observed in the Hyp mouse model of XLH

The Role Of Gdf5 Regulatory Regions In Development Of Hip Morphology

Clinical and Genetic Analysis in a Large Chinese Cohort of Patients with X-linked Hypophosphatemia

Specific deletion of Axin1 leads to activation of β-catenin/BMP signaling resulting in fibular hemimelia phenotype in mice

The pathogenic mechanism of syndactyly type V identified in a Hoxd13 Q50R knock-in mice

Growth Differentiation Factor 5 Regulation in Bone Regeneration

Mutant GDF5 Enhances Ameloblast Differentiation Via Accelerated BMP2-induced Smad1/5/8 Phosphorylation.

Sclerostin antibody improves alveolar bone quality in the Hyp mouse model of X-linked hypophosphatemia (XLH)

Molecular alterations due to Col5a1 haploinsufficiency in a mouse model of classic Ehlers-Danlos syndrome

Characterization of Novel PHEX Variants in X-linked Hypophosphatemic Rickets and Genotype-PHEX Activity Correlation

Investigating the Involvement of C−X−C Motif Chemokine 5 and P2X7 Purinoceptor in Ectopic Calcification in Mouse Models of Duchenne Muscular Dystrophy

Defective Joint Development and Maintenance in <i>GDF6</i>-Related Multiple Synostoses Syndrome

Ano5 modulates calcium signaling during bone homeostasis in gnathodiaphyseal dysplasia